Login / Signup
Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".
Hiroshi Ito
Published in:
Pharmacotherapy (2020)
Keyphrases
</>
clostridium difficile
methicillin resistant staphylococcus aureus
high dose
early onset
stem cells
mesenchymal stem cells
drug induced
hepatitis b virus
bone marrow
smoking cessation
replacement therapy